| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.35e-08 | 11 | 178 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.27e-08 | 37 | 178 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.97e-08 | 38 | 178 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.98e-08 | 14 | 178 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 9.64e-07 | 21 | 178 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | ATG2B TTPAL SNX13 SNX14 WDR45 EXOC1 PLCD1 ACAP2 RUBCN VPS13B | 1.23e-05 | 199 | 178 | 10 | GO:1901981 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.84e-05 | 37 | 178 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.10e-05 | 38 | 178 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 NEIL1 ERVK-7 MSH3 ERVK-10 RECQL4 ERVK-8 ERCC6L2 HFM1 NEIL3 ERVK-11 | 2.43e-05 | 262 | 178 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | ATG2B TTPAL SNX13 ITPR1 SNX14 WDR45 EXOC1 PLCD1 PLD2 ACAP2 RUBCN VPS13B | 2.79e-05 | 316 | 178 | 12 | GO:0035091 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.42e-05 | 46 | 178 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 NEIL1 POLRMT NARS1 ERVK-7 MSH3 ERVK-10 POLR3A ERI3 RECQL4 ERVK-8 ERCC6L2 HFM1 NEIL3 DDX60L ERVK-11 QARS1 | 6.79e-05 | 645 | 178 | 17 | GO:0140640 |
| GeneOntologyMolecularFunction | cholesterol dehydrogenase activity | 7.90e-05 | 2 | 178 | 2 | GO:0102294 | |
| GeneOntologyMolecularFunction | peptidase activity | USP49 ERVK-6 HINT1 DPP10 UFSP2 CASP2 ERVK-7 ERVK-10 DDI1 PREPL USP20 USP21 AFG3L2 ERVK-8 ERVK-18 ERVK-25 KLK1 | 8.04e-05 | 654 | 178 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO9A DYNC2H1 ATP8A2 MYO1H RNF213 MSH3 IQCA1L ATAD2B RECQL4 AFG3L2 ERCC6L2 KIF14 HFM1 DDX60L SMC1B VCP | 1.28e-04 | 614 | 178 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | endopeptidase activity | USP49 ERVK-6 CASP2 ERVK-7 ERVK-10 DDI1 PREPL USP20 AFG3L2 ERVK-8 ERVK-18 ERVK-25 KLK1 | 1.33e-04 | 430 | 178 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.21e-04 | 136 | 178 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | BIN1 GBP6 ADRM1 MYO9A DOCK8 LMTK2 GBP1 DENND2D TNFRSF10B BIRC6 OPHN1 ITIH5 TFPI TBC1D16 PLEKHG1 NGEF CST5 DOCK7 KNDC1 QARS1 DOCK6 ACAP2 RUBCN VCP PPP6R3 WDTC1 | 3.55e-04 | 1418 | 178 | 26 | GO:0030234 |
| GeneOntologyMolecularFunction | transition metal ion binding | USP49 ERVK-6 CYP2C19 CYP2C8 NEIL1 KDM5C ESR2 ERVK-7 ERVK-10 PPEF2 SCD5 USP20 POLR3A TRIM33 RNF146 RECQL4 AFG3L2 ERVK-8 ZNF638 NEIL3 DMD ERVK-11 PDZRN3 | 3.82e-04 | 1189 | 178 | 23 | GO:0046914 |
| GeneOntologyMolecularFunction | zinc ion binding | USP49 ERVK-6 NEIL1 KDM5C ESR2 ERVK-7 ERVK-10 USP20 POLR3A TRIM33 RNF146 RECQL4 AFG3L2 ERVK-8 ZNF638 NEIL3 DMD ERVK-11 PDZRN3 | 3.93e-04 | 891 | 178 | 19 | GO:0008270 |
| GeneOntologyMolecularFunction | phospholipid binding | BIN1 ATG2B TTPAL OPHN1 SNX13 ITPR1 SNX14 WDR45 EXOC1 PLCD1 PLD2 ACAP2 RUBCN VPS13B | 4.14e-04 | 548 | 178 | 14 | GO:0005543 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 4.34e-04 | 152 | 178 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 5.14e-04 | 257 | 178 | 9 | GO:0061134 | |
| GeneOntologyMolecularFunction | lipid binding | BIN1 ACADS ESR2 ATG2B GBP1 TTPAL OPHN1 SNX13 ITPR1 SNX14 WDR45 HSD3B1 EXOC1 HSD3B2 PLCD1 PLD2 ACAP2 RUBCN VPS13B VCP | 5.33e-04 | 988 | 178 | 20 | GO:0008289 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DYNC2H1 ATP8A2 RNF213 IQCA1L ATAD2B RECQL4 AFG3L2 KIF14 HFM1 DDX60L SMC1B VCP | 6.19e-04 | 441 | 178 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.04e-04 | 79 | 178 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 7.60e-04 | 121 | 178 | 6 | GO:1902936 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 8.75e-04 | 48 | 178 | 4 | GO:0032266 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | BIN1 GBP6 UACA ADRM1 ESR2 LMTK2 GBP1 BIRC6 ITIH5 TFPI ITPR1 CST5 QARS1 WDTC1 | 9.39e-04 | 596 | 178 | 14 | GO:0140678 |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.16e-03 | 6 | 178 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | 3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity | 1.16e-03 | 6 | 178 | 2 | GO:0003854 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 POLRMT NARS1 ERVK-7 ERVK-10 POLR3A ERI3 ERVK-8 DDX60L ERVK-11 QARS1 | 1.33e-03 | 417 | 178 | 11 | GO:0140098 |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 1.61e-03 | 7 | 178 | 2 | GO:0004769 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.94e-03 | 28 | 178 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MYO9A DOCK8 GBP1 DENND2D OPHN1 TBC1D16 PLEKHG1 NGEF DOCK7 KNDC1 DOCK6 ACAP2 | 2.03e-03 | 507 | 178 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MYO9A DOCK8 GBP1 DENND2D OPHN1 TBC1D16 PLEKHG1 NGEF DOCK7 KNDC1 DOCK6 ACAP2 | 2.03e-03 | 507 | 178 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.14e-03 | 8 | 178 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | class I DNA-(apurinic or apyrimidinic site) endonuclease activity | 2.14e-03 | 8 | 178 | 2 | GO:0140078 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.14e-03 | 8 | 178 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 2.14e-03 | 8 | 178 | 2 | GO:0000405 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.14e-03 | 8 | 178 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 2.14e-03 | 8 | 178 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 2.14e-03 | 8 | 178 | 2 | GO:0000253 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 2.21e-03 | 201 | 178 | 7 | GO:0061135 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 2.61e-03 | 31 | 178 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 2.61e-03 | 31 | 178 | 3 | GO:0080025 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 2.86e-03 | 32 | 178 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | oxidized purine DNA binding | 3.39e-03 | 10 | 178 | 2 | GO:0032357 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | GBP6 DRG2 DYNC2H1 ATP8A2 GBP1 RNF213 IQCA1L ATAD2B RECQL4 AFG3L2 KIF14 HFM1 DDX60L SMC1B VCP | 4.07e-03 | 775 | 178 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | oxidized DNA binding | 4.12e-03 | 11 | 178 | 2 | GO:0032356 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 4.12e-03 | 11 | 178 | 2 | GO:0101020 | |
| GeneOntologyBiologicalProcess | DNA integration | 5.20e-08 | 13 | 176 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.23e-06 | 48 | 176 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | SEMA4D BIN1 UACA MYO9A DOCK8 NEIL1 CASP2 BIRC6 ITIH5 SNX13 TFPI NEDD9 TBC1D16 NGEF CST5 DOCK7 LRP1 DOCK6 VCP PPP6R3 | 6.33e-05 | 878 | 176 | 20 | GO:0051336 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 7.77e-05 | 83 | 176 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | NEMP1 HK2 UFSP2 ATG2B RB1CC1 NEDD9 SNX14 WDR45 ATAD2B NGEF CST5 LRP1 KIF14 OGA RUBCN VCP | 8.14e-05 | 617 | 176 | 16 | GO:0022411 |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum membrane | 1.20e-04 | 12 | 175 | 3 | GO:0030868 | |
| GeneOntologyCellularComponent | host cellular component | 2.44e-04 | 15 | 175 | 3 | GO:0018995 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | UACA SYNE1 ESR2 LMTK2 GBP1 USP20 HNRNPL MAP3K4 ITPR1 LRPPRC FXR1 STXBP1 CST5 LRP1 EXOC1 DMD TNFRSF1B DOCK6 VCP | 3.23e-04 | 934 | 175 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | axon | KLHL24 BIN1 MYO9A PPFIA2 ROR1 INSRR LMTK2 OPHN1 LRIG2 FXR1 STXBP1 NGEF CST5 DOCK7 LRP1 DMD TNFRSF1B UNC80 | 5.05e-04 | 891 | 175 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | phagophore assembly site membrane | 7.90e-04 | 22 | 175 | 3 | GO:0034045 | |
| GeneOntologyCellularComponent | host intracellular region | 1.02e-03 | 6 | 175 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 1.02e-03 | 6 | 175 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 1.02e-03 | 6 | 175 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 1.02e-03 | 6 | 175 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 1.02e-03 | 6 | 175 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 1.02e-03 | 6 | 175 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 1.02e-03 | 6 | 175 | 2 | GO:0020005 | |
| Domain | DUF3398 | 1.45e-05 | 6 | 170 | 3 | PF11878 | |
| Domain | DOCK_C/D_N | 1.45e-05 | 6 | 170 | 3 | IPR021816 | |
| Domain | DHR-1_domain | 1.16e-04 | 11 | 170 | 3 | IPR027007 | |
| Domain | DHR_2 | 1.16e-04 | 11 | 170 | 3 | PS51651 | |
| Domain | DHR_1 | 1.16e-04 | 11 | 170 | 3 | PS51650 | |
| Domain | DHR-2 | 1.16e-04 | 11 | 170 | 3 | PF06920 | |
| Domain | DOCK | 1.16e-04 | 11 | 170 | 3 | IPR026791 | |
| Domain | DOCK_C | 1.16e-04 | 11 | 170 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 1.16e-04 | 11 | 170 | 3 | PF14429 | |
| Domain | DHR-2 | 1.16e-04 | 11 | 170 | 3 | IPR027357 | |
| Domain | FPG_cat | 2.46e-04 | 3 | 170 | 2 | IPR012319 | |
| Domain | FPG_CAT | 2.46e-04 | 3 | 170 | 2 | PS51068 | |
| Domain | Niban-like | 2.46e-04 | 3 | 170 | 2 | IPR026088 | |
| Domain | H2TH | 2.46e-04 | 3 | 170 | 2 | SM01232 | |
| Domain | DNA_glyclase/AP_lyase_DNA-bd | 2.46e-04 | 3 | 170 | 2 | IPR015886 | |
| Domain | Znf_DNA_glyclase/AP_lyase | 2.46e-04 | 3 | 170 | 2 | IPR000214 | |
| Domain | H2TH | 2.46e-04 | 3 | 170 | 2 | PF06831 | |
| Domain | Lys_sp_deMease-like_dom | 4.88e-04 | 4 | 170 | 2 | IPR013637 | |
| Domain | PXA | 4.88e-04 | 4 | 170 | 2 | SM00313 | |
| Domain | PXA | 4.88e-04 | 4 | 170 | 2 | PS51207 | |
| Domain | PXA | 4.88e-04 | 4 | 170 | 2 | PF02194 | |
| Domain | PLU-1 | 4.88e-04 | 4 | 170 | 2 | PF08429 | |
| Domain | Sorting_nexin_C | 4.88e-04 | 4 | 170 | 2 | IPR013937 | |
| Domain | Phox_assoc | 4.88e-04 | 4 | 170 | 2 | IPR003114 | |
| Domain | Nexin_C | 4.88e-04 | 4 | 170 | 2 | PF08628 | |
| Domain | Autophagy-rel_C | 8.09e-04 | 5 | 170 | 2 | IPR015412 | |
| Domain | zf-C5HC2 | 8.09e-04 | 5 | 170 | 2 | PF02928 | |
| Domain | ATG_C | 8.09e-04 | 5 | 170 | 2 | PF09333 | |
| Domain | Znf_C5HC2 | 8.09e-04 | 5 | 170 | 2 | IPR004198 | |
| Domain | Ribosomal_S13-like_H2TH | 8.09e-04 | 5 | 170 | 2 | IPR010979 | |
| Domain | 3Beta_HSD | 1.21e-03 | 6 | 170 | 2 | PF01073 | |
| Domain | 3Beta_OHSteriod_DH/Estase | 1.21e-03 | 6 | 170 | 2 | IPR002225 | |
| Domain | JmjC | 1.30e-03 | 24 | 170 | 3 | PF02373 | |
| Pubmed | VAPB DNAJC13 DRG2 UACA DYNC2H1 SYNE1 POLRMT UBE2M NIBAN2 TNFRSF10B RB1CC1 SCD5 PREPL ITPR1 TUBGCP6 GSTM3 LRIG2 PLEKHG1 LRPPRC TBC1D31 CDC123 AFG3L2 NUMB OGA TIMM44 VPS13B VCP PPP6R3 | 3.45e-09 | 1487 | 180 | 28 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJC13 HK2 MYO9A POLRMT NARS1 UBE2M MSH3 SRBD1 CMSS1 BIRC6 HNRNPL POLR3A CDCA2 LRPPRC PTPN12 FXR1 RECQL4 AFG3L2 ZNF638 EXOC1 DDX60L QARS1 TIMM44 VCP KPNA3 | 3.77e-08 | 1353 | 180 | 25 | 29467282 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VAPB USP49 KLHL24 ADRM1 DYNC2H1 NIBAN2 SRBD1 CMSS1 PREPL USP20 POLR3A USP21 LRPPRC AFG3L2 DOCK7 LRP1 OGA VCP PPP6R3 WDTC1 KPNA3 | 6.74e-08 | 1005 | 180 | 21 | 19615732 |
| Pubmed | VAPB DNAJC13 LMTK2 RNF213 NIBAN2 RB1CC1 PPEF2 BIRC6 HNRNPL ITPR1 CDCA2 PTPN12 PTPRB TBC1D31 AFG3L2 ZNF638 KIF14 NUMB DMD PPP6R3 KPNA3 | 1.37e-07 | 1049 | 180 | 21 | 27880917 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.43e-07 | 4 | 180 | 3 | 10469592 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 6.20e-07 | 94 | 180 | 7 | 21542922 | |
| Pubmed | DNAJC13 HK2 DRG2 DOCK8 SCYL1 RNF213 TTPAL MSH3 BIRC6 HNRNPL POLR3A ITPR1 TUBGCP6 LRPPRC FXR1 CSNK1G2 RECQL4 KIF14 EXOC1 OGA ACAP2 | 7.89e-07 | 1168 | 180 | 21 | 19946888 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.35e-06 | 5 | 180 | 3 | 12629516 | |
| Pubmed | 2.01e-06 | 18 | 180 | 4 | 18664271 | ||
| Pubmed | 4.70e-06 | 7 | 180 | 3 | 24105479 | ||
| Pubmed | VAPB BIN1 DNAJC13 MYO9A DOCK8 SYNE1 PPFIA2 NARS1 OPHN1 LRPPRC FXR1 STXBP1 PAFAH1B2 AFG3L2 STON2 NGEF DOCK7 KNDC1 EXOC1 DMD VCP KPNA3 | 5.40e-06 | 1431 | 180 | 22 | 37142655 | |
| Pubmed | Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy. | 7.49e-06 | 8 | 180 | 3 | 27798095 | |
| Pubmed | VAPB BIN1 HK2 ACADS ADRM1 PPFIA2 ATG2B LMTK2 SCD5 BIRC6 ITPR1 LRPPRC STXBP1 AFG3L2 DOCK7 KNDC1 EXOC1 TIMM44 VCP | 7.96e-06 | 1139 | 180 | 19 | 36417873 | |
| Pubmed | 8.72e-06 | 92 | 180 | 6 | 20301317 | ||
| Pubmed | DNAJC13 DRG2 ATG2B POLRMT RB1CC1 BIRC6 ARAF DOCK7 LRP1 KIF14 S100PBP | 1.27e-05 | 418 | 180 | 11 | 34709266 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.39e-05 | 208 | 180 | 8 | 33230847 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.76e-05 | 104 | 180 | 6 | 31240132 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | VAPB DNAJC13 ADRM1 DYNC2H1 ATG2B SCYL1 MMADHC ARAF USP21 LRPPRC PAFAH1B2 AFG3L2 DOCK7 ZNF638 NUMB EXOC1 QARS1 ACAP2 WDTC1 KPNA3 | 1.85e-05 | 1321 | 180 | 20 | 27173435 |
| Pubmed | HINT1 UACA ESR2 L1TD1 NIBAN2 ERVK-10 ITPR1 TUBGCP6 TBC1D16 TRIM33 PTPN12 RNF146 RECQL4 KIF14 FGF4 NEIL3 ERVK-25 RUBCN PPP6R3 | 1.95e-05 | 1215 | 180 | 19 | 15146197 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DRG2 POLRMT NARS1 BCAT1 UBE2M MSH3 BIRC6 HNRNPL MAP3K4 POLR3A TRIM33 FXR1 STXBP1 TIMM44 | 2.00e-05 | 704 | 180 | 14 | 29955894 |
| Pubmed | INSRR SCYL1 MSH3 RB1CC1 PTPRB PAFAH1B2 ZNF638 EXOC1 TIMM44 ACAP2 | 2.01e-05 | 360 | 180 | 10 | 33111431 | |
| Pubmed | UACA KDM5C POLRMT L1TD1 RNF213 TNFRSF10B ARAF TUBGCP6 TRIM33 FXR1 AFG3L2 LRP1 FIBP PDZRN3 UNC80 VCP WDTC1 KPNA3 | 2.18e-05 | 1116 | 180 | 18 | 31753913 | |
| Pubmed | Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol. | 2.66e-05 | 2 | 180 | 2 | 14665668 | |
| Pubmed | The novel DNA glycosylase, NEIL1, protects mammalian cells from radiation-mediated cell death. | 2.66e-05 | 2 | 180 | 2 | 12713815 | |
| Pubmed | Chaperones rejuvenate folding and activity of 3-β hydroxysteroid dehydrogenase 2. | 2.66e-05 | 2 | 180 | 2 | 23485106 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18524572 | ||
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 2.66e-05 | 2 | 180 | 2 | 10441747 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 19414525 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 28513222 | ||
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 2.66e-05 | 2 | 180 | 2 | 16416087 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18778748 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 9029734 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 9029733 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 29234069 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 2243100 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12205101 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 24075909 | ||
| Pubmed | 3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. | 2.66e-05 | 2 | 180 | 2 | 25458695 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20890775 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12050213 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25242522 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 7608280 | ||
| Pubmed | The Biochemical Role of the Human NEIL1 and NEIL3 DNA Glycosylases on Model DNA Replication Forks. | 2.66e-05 | 2 | 180 | 2 | 31018584 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 32081420 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20660004 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 34550611 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 14764797 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23926102 | ||
| Pubmed | High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians. | 2.66e-05 | 2 | 180 | 2 | 37274334 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 1924345 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 16478974 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 7524912 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 30851938 | ||
| Pubmed | Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. | 2.66e-05 | 2 | 180 | 2 | 22491019 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 7626443 | ||
| Pubmed | Processing of N5-substituted formamidopyrimidine DNA adducts by DNA glycosylases NEIL1 and NEIL3. | 2.66e-05 | 2 | 180 | 2 | 30448017 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12433996 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8145763 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 19170771 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 33253217 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11133676 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 2066113 | ||
| Pubmed | Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy. | 2.66e-05 | 2 | 180 | 2 | 24200690 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11912155 | ||
| Pubmed | Association of the variations in the HSD3β gene with primary aldosteronism. | 2.66e-05 | 2 | 180 | 2 | 24006038 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 1944309 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8647315 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 7491113 | ||
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 2.66e-05 | 2 | 180 | 2 | 9060413 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12530651 | ||
| Pubmed | Isolation and characterization of several members of the murine Hsd3b gene family. | 2.66e-05 | 2 | 180 | 2 | 8924213 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10103023 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 9075693 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17689071 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.66e-05 | 2 | 180 | 2 | 11672541 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 30974833 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SEMA4D DNAJC13 UACA MYO9A NEIL1 PPFIA2 RNF213 HPS3 HNRNPL LRPPRC PTPRB GUCY1A1 ERI3 NGEF KNDC1 LRP1 ZNF638 NUMB GREB1 DOCK6 VPS13B | 3.21e-05 | 1489 | 180 | 21 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | VAPB NEMP1 HINT1 HK2 SYNE1 ATG2B POLRMT SCYL1 RNF213 BIRC6 PREPL ARAF HNRNPL POLR3A ITPR1 LRPPRC FXR1 AFG3L2 TIMM44 VPS13B VCP | 3.43e-05 | 1496 | 180 | 21 | 32877691 |
| Pubmed | 3.75e-05 | 13 | 180 | 3 | 25648896 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.96e-05 | 120 | 180 | 6 | 31413325 | |
| Pubmed | ADRM1 DYNC2H1 CWC27 SYNE1 SCYL1 ARAF HNRNPL ITPR1 TRIM33 ZNF638 KIF14 DMD OGA ACAP2 | 4.21e-05 | 754 | 180 | 14 | 35906200 | |
| Pubmed | 4.35e-05 | 179 | 180 | 7 | 19074885 | ||
| Pubmed | VAPB DNAJC13 DRG2 ADRM1 POLRMT UBE2M RB1CC1 CMSS1 BIRC6 GSTM3 LRPPRC PTPN12 CDC123 AFG3L2 NUMB QARS1 VCP PPP6R3 KPNA3 | 4.72e-05 | 1297 | 180 | 19 | 33545068 | |
| Pubmed | 4.76e-05 | 14 | 180 | 3 | 20970553 | ||
| Pubmed | 4.76e-05 | 14 | 180 | 3 | 12432077 | ||
| Pubmed | 4.98e-05 | 125 | 180 | 6 | 29467281 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | VAPB ADRM1 POLRMT PREPL ARAF HNRNPL LRIG2 LRPPRC PTPN12 FXR1 AFG3L2 LRP1 PLD2 DMD VCP PPP6R3 | 5.13e-05 | 974 | 180 | 16 | 28675297 |
| Pubmed | BIN1 HK2 UACA SYNE1 BIRC6 PREPL NEDD9 LRPPRC AFG3L2 EXOC1 VCP | 6.15e-05 | 497 | 180 | 11 | 23414517 | |
| Pubmed | VAPB HK2 UACA POLRMT NARS1 RNF213 HNRNPL POLR3A ITPR1 LRPPRC AFG3L2 DOCK7 KIF14 EXOC1 DDX60L QARS1 TIMM44 VCP PPP6R3 KPNA3 | 6.17e-05 | 1440 | 180 | 20 | 30833792 | |
| Pubmed | VAPB DNAJC13 ATG2B SCD5 HPS3 ITPR1 LRIG2 SNX14 WDR45 DOCK6 VPS13B | 6.96e-05 | 504 | 180 | 11 | 34432599 | |
| Pubmed | 7.31e-05 | 43 | 180 | 4 | 18510611 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | DNAJC13 MYO9A ROR1 INSRR SCYL1 LMTK2 PTPN12 PTPRB LRP1 UNC80 | 7.32e-05 | 420 | 180 | 10 | 28065597 |
| Pubmed | 7.96e-05 | 3 | 180 | 2 | 27042257 | ||
| Pubmed | Embryonic expression of Fgf-6 is restricted to the skeletal muscle lineage. | 7.96e-05 | 3 | 180 | 2 | 8344469 | |
| Pubmed | 7.96e-05 | 3 | 180 | 2 | 22875961 | ||
| Pubmed | 7.96e-05 | 3 | 180 | 2 | 35134542 | ||
| Pubmed | 7.96e-05 | 3 | 180 | 2 | 9971820 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 7.96e-05 | 3 | 180 | 2 | 21977947 | |
| Pubmed | Identification and characterization of PDZRN3 and PDZRN4 genes in silico. | 7.96e-05 | 3 | 180 | 2 | 15010864 | |
| Pubmed | 7.96e-05 | 3 | 180 | 2 | 37418531 | ||
| Interaction | PSMC6 interactions | ADRM1 ESR2 UBE2M DDI1 RB1CC1 KDM6B GSTM3 LRPPRC CDC123 RECQL4 KIF14 QARS1 VCP WDTC1 | 1.29e-06 | 342 | 170 | 14 | int:PSMC6 |
| Interaction | PLEC interactions | GBP6 MYO9A ESR2 ROR1 WDFY4 USP20 HNRNPL ITPR1 AXDND1 RECQL4 KIF14 NEIL3 PLCD1 QARS1 VCP | 3.86e-06 | 430 | 170 | 15 | int:PLEC |
| Interaction | CSDE1 interactions | ADRM1 ESR2 HNRNPL TRIM33 FXR1 STXBP1 CDC123 RECQL4 KIF14 NEIL3 FAM9B WDTC1 | 5.51e-06 | 284 | 170 | 12 | int:CSDE1 |
| Interaction | PEX14 interactions | DYNC2H1 LMTK2 KDM5D BIRC6 HNRNPL NEDD9 PLEKHG1 LRPPRC AFG3L2 KIF14 FGF4 | 5.64e-06 | 237 | 170 | 11 | int:PEX14 |
| Interaction | PPP1R12C interactions | 9.28e-06 | 58 | 170 | 6 | int:PPP1R12C | |
| Interaction | SORT1 interactions | UFSP2 UACA ESR2 SCYL1 LMTK2 WDFY4 CNIH3 MAP3K4 CDC123 CSNK1G2 | 1.12e-05 | 208 | 170 | 10 | int:SORT1 |
| Interaction | UQCC5 interactions | 1.16e-05 | 6 | 170 | 3 | int:UQCC5 | |
| Interaction | CISD3 interactions | 1.29e-05 | 92 | 170 | 7 | int:CISD3 | |
| Interaction | RHOF interactions | VAPB DRG2 UACA DOCK8 ESR2 MSH3 NIBAN2 TNFRSF10B WDR45 CDC123 AFG3L2 STON2 DOCK7 FIBP KIF14 NUMB VPS13B VCP | 1.62e-05 | 673 | 170 | 18 | int:RHOF |
| Interaction | PSMD6 interactions | ADRM1 ESR2 UBE2M DDI1 ARAF USP20 LRPPRC CDC123 RECQL4 QARS1 VCP WDTC1 | 1.66e-05 | 317 | 170 | 12 | int:PSMD6 |
| Interaction | LRCH4 interactions | 1.84e-05 | 39 | 170 | 5 | int:LRCH4 | |
| Interaction | MAIP1 interactions | 1.95e-05 | 98 | 170 | 7 | int:MAIP1 | |
| Interaction | UACA interactions | 2.05e-05 | 136 | 170 | 8 | int:UACA | |
| Interaction | PPP6C interactions | ESR2 POLRMT BIRC6 ARAF LRPPRC CDC123 RECQL4 VCP PPP6R3 WDTC1 | 2.47e-05 | 228 | 170 | 10 | int:PPP6C |
| Interaction | SKAP1 interactions | 2.53e-05 | 102 | 170 | 7 | int:SKAP1 | |
| Interaction | CHD1L interactions | 2.53e-05 | 102 | 170 | 7 | int:CHD1L | |
| Interaction | APBA1 interactions | 2.70e-05 | 103 | 170 | 7 | int:APBA1 | |
| Interaction | CORO1A interactions | 2.80e-05 | 142 | 170 | 8 | int:CORO1A | |
| Interaction | SLIRP interactions | ESR2 POLRMT BIRC6 PREPL HNRNPL LRPPRC CDC123 RECQL4 AFG3L2 KIF14 TIMM44 VCP | 3.12e-05 | 338 | 170 | 12 | int:SLIRP |
| Interaction | HSPA9 interactions | DNAJC13 ADRM1 UBE2M DENND2D ARAF USP20 HNRNPL ITPR1 GSTM3 LRPPRC FXR1 STXBP1 RNF146 RECQL4 AFG3L2 GREB1 QARS1 TIMM44 | 4.46e-05 | 727 | 170 | 18 | int:HSPA9 |
| Interaction | AP2A2 interactions | 5.00e-05 | 199 | 170 | 9 | int:AP2A2 | |
| Interaction | FKBP5 interactions | USP49 DRG2 INSRR KDM6B ARAF HPS3 HNRNPL GSTM3 RECQL4 NEIL3 PLD2 OGA WDTC1 | 5.19e-05 | 414 | 170 | 13 | int:FKBP5 |
| Interaction | GSTZ1 interactions | 6.32e-05 | 26 | 170 | 4 | int:GSTZ1 | |
| Interaction | RPS27L interactions | 6.53e-05 | 206 | 170 | 9 | int:RPS27L | |
| Interaction | OSGEPL1 interactions | 6.78e-05 | 10 | 170 | 3 | int:OSGEPL1 | |
| Interaction | MAGEA9 interactions | 7.03e-05 | 208 | 170 | 9 | int:MAGEA9 | |
| Interaction | MYH9 interactions | UACA ADRM1 ESR2 UBE2M WDFY4 USP20 NEDD9 TRIM33 LRPPRC FXR1 TBC1D31 CDC123 STON2 DOCK7 KIF14 VCP PPP6R3 WDTC1 | 7.12e-05 | 754 | 170 | 18 | int:MYH9 |
| Interaction | HNRNPLL interactions | 7.45e-05 | 163 | 170 | 8 | int:HNRNPLL | |
| Interaction | PSMB7 interactions | 7.85e-05 | 211 | 170 | 9 | int:PSMB7 | |
| Interaction | SLC25A22 interactions | 7.97e-05 | 122 | 170 | 7 | int:SLC25A22 | |
| Interaction | HYOU1 interactions | BIN1 HK2 ROR1 UBE2M WDFY4 TRIM33 CDC123 RECQL4 KIF14 DOCK6 VCP | 8.24e-05 | 317 | 170 | 11 | int:HYOU1 |
| Interaction | PSMB2 interactions | 8.44e-05 | 213 | 170 | 9 | int:PSMB2 | |
| Interaction | TENM1 interactions | 8.54e-05 | 28 | 170 | 4 | int:TENM1 | |
| Interaction | SLFN11 interactions | KDM5C ESR2 RNF213 RB1CC1 KDM6B HNRNPL TRIM33 KIF14 HFM1 TUBD1 PDZRN3 VCP | 8.69e-05 | 376 | 170 | 12 | int:SLFN11 |
| Interaction | PDK3 interactions | 9.29e-05 | 125 | 170 | 7 | int:PDK3 | |
| Interaction | DCUN1D3 interactions | 9.85e-05 | 29 | 170 | 4 | int:DCUN1D3 | |
| Interaction | MAP4 interactions | ADRM1 UBE2M HNRNPL USP21 GSTM3 TRIM33 LRPPRC STXBP1 CKAP2L NEIL3 QARS1 | 1.00e-04 | 324 | 170 | 11 | int:MAP4 |
| Interaction | GPS1 interactions | 1.01e-04 | 218 | 170 | 9 | int:GPS1 | |
| Interaction | TRIOBP interactions | 1.03e-04 | 127 | 170 | 7 | int:TRIOBP | |
| Interaction | KARS1 interactions | ESR2 LMTK2 NARS1 MSH3 KDM6B HNRNPL LRPPRC CDC123 RECQL4 KIF14 QARS1 VCP | 1.03e-04 | 383 | 170 | 12 | int:KARS1 |
| Interaction | PPP5C interactions | 1.09e-04 | 272 | 170 | 10 | int:PPP5C | |
| Interaction | PSMD12 interactions | ADRM1 UBE2M DDI1 USP20 POLR3A LRPPRC CDC123 RECQL4 KIF14 DOCK6 VCP | 1.21e-04 | 331 | 170 | 11 | int:PSMD12 |
| Interaction | UNC80 interactions | 1.23e-04 | 12 | 170 | 3 | int:UNC80 | |
| Interaction | XRCC5 interactions | BIN1 ADRM1 ESR2 NARS1 UBE2M ARAF HNRNPL TRIM33 CDC123 RNF146 RECQL4 KIF14 NEIL3 VCP | 1.24e-04 | 515 | 170 | 14 | int:XRCC5 |
| Interaction | NPEPPS interactions | 1.32e-04 | 177 | 170 | 8 | int:NPEPPS | |
| Interaction | RARS1 interactions | ESR2 NARS1 UBE2M HNRNPL GSTM3 TRIM33 LRPPRC CDC123 RECQL4 QARS1 VCP | 1.38e-04 | 336 | 170 | 11 | int:RARS1 |
| Interaction | DUSP26 interactions | 1.40e-04 | 59 | 170 | 5 | int:DUSP26 | |
| Interaction | RCN2 interactions | 1.46e-04 | 282 | 170 | 10 | int:RCN2 | |
| Interaction | MRPS17 interactions | 1.46e-04 | 229 | 170 | 9 | int:MRPS17 | |
| Interaction | KIFBP interactions | 1.48e-04 | 180 | 170 | 8 | int:KIFBP | |
| Interaction | ATP5MK interactions | 1.50e-04 | 135 | 170 | 7 | int:ATP5MK | |
| Interaction | YWHAH interactions | VAPB DRG2 UACA MYO9A ESR2 LMTK2 UBE2M RB1CC1 ARAF USP21 CDCA2 PLEKHG1 FXR1 CDC123 RECQL4 DOCK7 ZNF638 KIF14 NUMB DOCK6 RUBCN VCP | 1.53e-04 | 1102 | 170 | 22 | int:YWHAH |
| Interaction | SPAST interactions | 1.57e-04 | 136 | 170 | 7 | int:SPAST | |
| Interaction | ITIH5 interactions | 1.58e-04 | 13 | 170 | 3 | int:ITIH5 | |
| Interaction | DHX9 interactions | BIN1 GBP6 ROR1 L1TD1 LMTK2 RB1CC1 ARAF HNRNPL TRIM33 LRPPRC CDC123 RECQL4 KIF14 NEIL3 QARS1 OGA | 1.59e-04 | 662 | 170 | 16 | int:DHX9 |
| Interaction | ARHGDIA interactions | 1.60e-04 | 182 | 170 | 8 | int:ARHGDIA | |
| Interaction | ACAT1 interactions | 1.61e-04 | 232 | 170 | 9 | int:ACAT1 | |
| Interaction | PHF21A interactions | DNAJC13 DRG2 ATG2B POLRMT RB1CC1 BIRC6 ARAF DOCK7 KIF14 EXOC1 S100PBP | 1.65e-04 | 343 | 170 | 11 | int:PHF21A |
| Interaction | EPS15L1 interactions | 1.72e-04 | 138 | 170 | 7 | int:EPS15L1 | |
| Interaction | PPP1CB interactions | UACA ADRM1 ESR2 LMTK2 RNF213 RB1CC1 HNRNPL CDCA2 STXBP1 CDC123 STON2 ZNF638 KIF14 | 1.80e-04 | 469 | 170 | 13 | int:PPP1CB |
| Interaction | ZCCHC10 interactions | 1.83e-04 | 236 | 170 | 9 | int:ZCCHC10 | |
| Interaction | RHOA interactions | VAPB MYO9A POLRMT TTPAL NIBAN2 DNAL1 TNFRSF10B SCD5 OPHN1 ITPR1 PTPN12 FXR1 PAFAH1B2 AFG3L2 STON2 NGEF DOCK7 FIBP KIF14 NUMB TIMM44 VPS13B VCP | 1.92e-04 | 1199 | 170 | 23 | int:RHOA |
| Interaction | FKBP15 interactions | 1.93e-04 | 99 | 170 | 6 | int:FKBP15 | |
| Interaction | MRPL10 interactions | 2.00e-04 | 188 | 170 | 8 | int:MRPL10 | |
| Interaction | EP400P1 interactions | 2.00e-04 | 14 | 170 | 3 | int:EP400P1 | |
| Interaction | CLTA interactions | DOCK8 ESR2 WDFY4 HNRNPL WDR45 FXR1 CDC123 STON2 KIF14 NUMB VCP | 2.01e-04 | 351 | 170 | 11 | int:CLTA |
| Interaction | KPNA1 interactions | ESR2 UBE2M SRBD1 KDM6B HNRNPL CDCA2 TRIM33 CDC123 RECQL4 TIMM44 KPNA3 | 2.01e-04 | 351 | 170 | 11 | int:KPNA1 |
| Interaction | COPA interactions | VAPB USP49 ESR2 SCYL1 UBE2M ARAF TRIM33 CDC123 NGEF KIF14 VCP WDTC1 | 2.04e-04 | 412 | 170 | 12 | int:COPA |
| Interaction | RAN interactions | NEMP1 ESR2 UBE2M WDFY4 ARAF GSTM3 CDCA2 CDC123 RECQL4 KIF14 QARS1 VCP KPNA3 | 2.04e-04 | 475 | 170 | 13 | int:RAN |
| Interaction | PSMD11 interactions | ADRM1 ESR2 UBE2M DDI1 WDFY4 USP20 GSTM3 LRPPRC CDC123 RECQL4 VCP | 2.11e-04 | 353 | 170 | 11 | int:PSMD11 |
| Interaction | LRCH1 interactions | 2.21e-04 | 65 | 170 | 5 | int:LRCH1 | |
| Interaction | HPS6 interactions | 2.33e-04 | 36 | 170 | 4 | int:HPS6 | |
| Interaction | TUFM interactions | POLRMT BIRC6 PREPL ARAF HNRNPL POLR3A GSTM3 LRPPRC CDC123 RECQL4 PAFAH1B2 AFG3L2 KIF14 FAM9B TIMM44 VCP | 2.37e-04 | 686 | 170 | 16 | int:TUFM |
| Interaction | COPS3 interactions | 2.42e-04 | 245 | 170 | 9 | int:COPS3 | |
| Interaction | MYH10 interactions | ADRM1 UBE2M BIRC6 WDFY4 USP20 HNRNPL TRIM33 FXR1 CDC123 KIF14 PPP6R3 | 2.44e-04 | 359 | 170 | 11 | int:MYH10 |
| Interaction | PSMC5 interactions | USP49 ADRM1 ESR2 UBE2M DDI1 RB1CC1 BIRC6 LRPPRC FXR1 CDC123 RECQL4 KIF14 VCP | 2.44e-04 | 484 | 170 | 13 | int:PSMC5 |
| Interaction | RAC1 interactions | VAPB BIN1 DOCK8 ESR2 UBE2M NIBAN2 TNFRSF10B RB1CC1 OPHN1 MAP3K4 PLEKHG1 LRPPRC CDC123 AFG3L2 STON2 DOCK7 FIBP KIF14 NUMB DOCK6 VCP | 2.51e-04 | 1063 | 170 | 21 | int:RAC1 |
| Interaction | CEP89 interactions | 2.54e-04 | 147 | 170 | 7 | int:CEP89 | |
| Interaction | BAG2 interactions | USP49 DNAJC13 UBE2M ARAF TUBGCP6 TRIM33 CDC123 RECQL4 DOCK7 KIF14 GREB1 PLD2 VPS13B VCP WDTC1 | 2.62e-04 | 622 | 170 | 15 | int:BAG2 |
| Interaction | SPIN1 interactions | 2.66e-04 | 105 | 170 | 6 | int:SPIN1 | |
| Interaction | PSMC3 interactions | ADRM1 ESR2 UBE2M DDI1 RB1CC1 KDM6B LRPPRC FXR1 CDC123 RECQL4 KIF14 VCP | 2.70e-04 | 425 | 170 | 12 | int:PSMC3 |
| Interaction | SRSF7 interactions | ESR2 SCYL1 RB1CC1 TFPI FXR1 CDC123 RECQL4 ZNF638 KIF14 QARS1 DUSP11 WDTC1 | 2.70e-04 | 425 | 170 | 12 | int:SRSF7 |
| Interaction | ANAPC10 interactions | 2.73e-04 | 68 | 170 | 5 | int:ANAPC10 | |
| Interaction | CALM1 interactions | BIN1 DNAJC13 KDM5C ESR2 POLRMT UBE2M PPEF2 USP20 ITPR1 PHKA2 TRIM33 LRPPRC DOCK7 KIF14 PLCD1 | 2.80e-04 | 626 | 170 | 15 | int:CALM1 |
| Interaction | HSPA4L interactions | 2.81e-04 | 250 | 170 | 9 | int:HSPA4L | |
| Interaction | SDF4 interactions | 2.99e-04 | 151 | 170 | 7 | int:SDF4 | |
| Interaction | YWHAZ interactions | VAPB BIN1 UACA MYO9A CWC27 PPFIA2 ESR2 UBE2M RB1CC1 ARAF HNRNPL MAP3K4 ITPR1 USP21 LRPPRC CDC123 RECQL4 CTNNA3 DOCK7 ZNF638 KIF14 NUMB RUBCN VCP | 3.02e-04 | 1319 | 170 | 24 | int:YWHAZ |
| Interaction | PCED1A interactions | 3.05e-04 | 16 | 170 | 3 | int:PCED1A | |
| Interaction | LRCH3 interactions | 3.10e-04 | 108 | 170 | 6 | int:LRCH3 | |
| Interaction | BECN1 interactions | 3.14e-04 | 201 | 170 | 8 | int:BECN1 | |
| Interaction | CDC42 interactions | VAPB ADRM1 MYO9A DOCK8 DYNC2H1 SYNE1 ESR2 SCYL1 MSH3 NIBAN2 TNFRSF10B RB1CC1 OPHN1 MAP3K4 ITPR1 PLEKHG1 CDC123 RECQL4 AFG3L2 STON2 DOCK7 KIF14 NUMB VCP | 3.15e-04 | 1323 | 170 | 24 | int:CDC42 |
| Interaction | EIF4G1 interactions | A1CF ADRM1 ESR2 UBE2M TRIM33 LRPPRC FXR1 CDC123 RECQL4 KIF14 QARS1 VCP | 3.20e-04 | 433 | 170 | 12 | int:EIF4G1 |
| Interaction | RNF213 interactions | 3.24e-04 | 153 | 170 | 7 | int:RNF213 | |
| Interaction | MYL6 interactions | 3.25e-04 | 255 | 170 | 9 | int:MYL6 | |
| Interaction | DHRS7B interactions | 3.26e-04 | 109 | 170 | 6 | int:DHRS7B | |
| Interaction | PCM1 interactions | MYO9A ESR2 RB1CC1 HNRNPL PLEKHG1 FXR1 TBC1D31 CDC123 CKAP2L KIF14 FAM9B PDZRN3 | 3.27e-04 | 434 | 170 | 12 | int:PCM1 |
| Interaction | HADHA interactions | USP49 ACADS ESR2 UBE2M RB1CC1 TRIM33 LRPPRC CDC123 CSNK1G2 RECQL4 KIF14 VCP PPP6R3 KPNA3 | 3.33e-04 | 567 | 170 | 14 | int:HADHA |
| Interaction | PSMD2 interactions | ADRM1 ESR2 UBE2M DDI1 POLR3A ITPR1 TRIM33 LRPPRC CDC123 RECQL4 KIF14 VCP | 3.34e-04 | 435 | 170 | 12 | int:PSMD2 |
| Interaction | ARHGEF2 interactions | 3.34e-04 | 256 | 170 | 9 | int:ARHGEF2 | |
| Interaction | YWHAG interactions | VAPB UACA MYO9A ESR2 LMTK2 UBE2M RB1CC1 PPEF2 ARAF USP21 CDCA2 PLEKHG1 FXR1 CDC123 RECQL4 PAFAH1B2 DOCK7 ZNF638 KIF14 NUMB RUBCN VCP PPP6R3 | 3.40e-04 | 1248 | 170 | 23 | int:YWHAG |
| Cytoband | 1p13.1 | 8.56e-06 | 33 | 180 | 4 | 1p13.1 | |
| Cytoband | 1p22.2 | 1.81e-04 | 28 | 180 | 3 | 1p22.2 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.83e-04 | 24 | 108 | 3 | 485 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DNAJC13 ROR1 MSH3 RB1CC1 MAP3K4 SNX13 TFPI ITPR1 TRIM33 LRPPRC PTPN12 FXR1 TBC1D31 ATAD2B ZNF638 KIF14 NUMB DMD ACAP2 VPS13B KPNA3 | 1.85e-07 | 856 | 170 | 21 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.82e-05 | 84 | 170 | 6 | M13008 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.41e-05 | 180 | 170 | 8 | M8239 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | DNAJC13 MYO9A CWC27 L1TD1 NARS1 MSH3 RB1CC1 SNX13 ITPR1 TRIM33 FXR1 ZNF257 ZNF638 KIF14 EXOC1 | 2.62e-05 | 656 | 170 | 15 | M18979 |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN | 3.54e-05 | 190 | 170 | 8 | M9428 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 4.92e-05 | 199 | 170 | 8 | M6646 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN | 5.09e-05 | 200 | 170 | 8 | M8056 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP | 5.09e-05 | 200 | 170 | 8 | M4545 | |
| Coexpression | GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN | 5.09e-05 | 200 | 170 | 8 | M9625 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 5.09e-05 | 200 | 170 | 8 | M6447 | |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | 7.53e-05 | 272 | 170 | 9 | MM3634 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-08 | 188 | 171 | 9 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-08 | 188 | 171 | 9 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-08 | 188 | 171 | 9 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 5.21e-08 | 189 | 171 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.55e-07 | 165 | 171 | 8 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-07 | 165 | 171 | 8 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.38e-07 | 182 | 171 | 8 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.06e-07 | 192 | 171 | 8 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.38e-07 | 193 | 171 | 8 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.38e-07 | 193 | 171 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.72e-07 | 194 | 171 | 8 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 160 | 171 | 7 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-06 | 165 | 171 | 7 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 175 | 171 | 7 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-06 | 179 | 171 | 7 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 183 | 171 | 7 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.02e-06 | 183 | 171 | 7 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 7.53e-06 | 185 | 171 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 7.80e-06 | 186 | 171 | 7 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, Lineage and Cell Type | 8.36e-06 | 188 | 171 | 7 | ee1bb0700ab70e03a63982446a33976b9200ddb6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-06 | 190 | 171 | 7 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-06 | 190 | 171 | 7 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.59e-06 | 192 | 171 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-06 | 193 | 171 | 7 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 9.92e-06 | 193 | 171 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.92e-06 | 193 | 171 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-06 | 193 | 171 | 7 | 444de545117dae8ab24a22880583ac2f0b2d6eac | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-05 | 194 | 171 | 7 | e9c907b8ec4329946338cca5ce8e954fa2cec37b | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-05 | 195 | 171 | 7 | 751cb00b0f3005be6b645adadfbb9dd2215b6e08 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.10e-05 | 196 | 171 | 7 | c450cd6b799932f5cce8326d1079114abeb71e95 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-05 | 197 | 171 | 7 | 9837bd2cc28b79147fb5d1997631ef953fd020e4 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.13e-05 | 197 | 171 | 7 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.13e-05 | 197 | 171 | 7 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-05 | 197 | 171 | 7 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-05 | 197 | 171 | 7 | e9327b133dab5f6a187cd8713f07205c948ec600 | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.13e-05 | 197 | 171 | 7 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.13e-05 | 197 | 171 | 7 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 198 | 171 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-05 | 200 | 171 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.25e-05 | 200 | 171 | 7 | e945dd467dc90b8042982051d1bf76b72a4baf5b | |
| ToppCell | severe-B_naive|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-05 | 200 | 171 | 7 | 306df1f498ac2188eaf9f2a8d002bb73bdb9642d | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 134 | 171 | 6 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-13|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.99e-05 | 144 | 171 | 6 | b2a9f3b5dd46d27689467f4a5fd717cd5827821f | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-mDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 147 | 171 | 6 | 26bd9d89e2e7b841cc18030bb7cebb642b987183 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 154 | 171 | 6 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.74e-05 | 161 | 171 | 6 | 6cacae4a759ace763597ee394cff498dc5d96f74 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 162 | 171 | 6 | 768a566e76923323c1f197f60bab472a8784490b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-05 | 163 | 171 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.28e-05 | 165 | 171 | 6 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 4.43e-05 | 166 | 171 | 6 | 13bef304ea3df8e8d2bc376a3287c78220a1b0c6 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-05 | 171 | 171 | 6 | 3d60e7ecf25e4b781ba2387671b2aad247fb75ff | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 173 | 171 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 173 | 171 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 173 | 171 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 174 | 171 | 6 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 174 | 171 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 174 | 171 | 6 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 5.76e-05 | 174 | 171 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 174 | 171 | 6 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-05 | 174 | 171 | 6 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.94e-05 | 175 | 171 | 6 | 553e68e8b439a2293efb969e1e2aa017ceb80daf | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.94e-05 | 175 | 171 | 6 | 16d4e97271df1db9a0d167fc82a90d84d20dd1f2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.94e-05 | 175 | 171 | 6 | 289d2aa7164bc02b1876b99f2fb67baa8e030c4e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.13e-05 | 176 | 171 | 6 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | Adult-Immune-dendritic_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.13e-05 | 176 | 171 | 6 | 1f0f1f953e6d61119f342de0d980aa1287511dba | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 6.13e-05 | 176 | 171 | 6 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 6.33e-05 | 177 | 171 | 6 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-05 | 177 | 171 | 6 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-05 | 177 | 171 | 6 | 325c10674b18727ddd50bf088a9c6f4ef29aa809 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.33e-05 | 177 | 171 | 6 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 177 | 171 | 6 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 177 | 171 | 6 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 177 | 171 | 6 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 177 | 171 | 6 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.53e-05 | 178 | 171 | 6 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.63e-05 | 110 | 171 | 5 | f626f0fdd1bff9c4970af14524ebdbdad8b67178 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-05 | 179 | 171 | 6 | 716856b2c7c660bf5ce00e63efeda6ed121f2baa | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.73e-05 | 179 | 171 | 6 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.94e-05 | 180 | 171 | 6 | a0b35067b6f2dbd8145da8bab760e9f650f045b0 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.94e-05 | 180 | 171 | 6 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.16e-05 | 181 | 171 | 6 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 7.16e-05 | 181 | 171 | 6 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-05 | 181 | 171 | 6 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-05 | 181 | 171 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 7.16e-05 | 181 | 171 | 6 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 182 | 171 | 6 | 2ef6889321fd0104d277518d130e19143b3af41c | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.38e-05 | 182 | 171 | 6 | 63c3b63315276b66667d49fab09661ac320e7a36 | |
| ToppCell | NS-control-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.38e-05 | 182 | 171 | 6 | 4b9b55154a79992112c1c467e8752c3cdbb541d9 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 7.61e-05 | 183 | 171 | 6 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 7.61e-05 | 183 | 171 | 6 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 7.61e-05 | 183 | 171 | 6 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.61e-05 | 183 | 171 | 6 | dbc7ec66da5930c2bf4e0405937b054e04c22a34 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.84e-05 | 184 | 171 | 6 | e6bf826be31e1723e24c366fc5a1cee9b15589bc | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.84e-05 | 184 | 171 | 6 | f4c9272d5cc4a70df051413b5c60ca6d1d80eb84 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.08e-05 | 185 | 171 | 6 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-05 | 185 | 171 | 6 | e29079ef09aee62c3e9756341db4e59ca9dbf7ac | |
| Drug | Trilostane | 1.63e-06 | 4 | 170 | 3 | DB01108 | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; PC3; HT_HG-U133A | BIN1 ACADS CASP2 TNFRSF10B KDM6B SCD5 SNX13 PRDM10 PTPN12 OGA | 2.39e-06 | 197 | 170 | 10 | 7143_UP |
| Disease | Uterine leiomyoma | 1.44e-05 | 91 | 169 | 6 | HP_0000131 | |
| Disease | Spinocerebellar Ataxia Type 2 | 4.21e-05 | 34 | 169 | 4 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 4.21e-05 | 34 | 169 | 4 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 4.21e-05 | 34 | 169 | 4 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 4.21e-05 | 34 | 169 | 4 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 4.21e-05 | 34 | 169 | 4 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 4.21e-05 | 34 | 169 | 4 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 4.73e-05 | 35 | 169 | 4 | C0752122 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 9.78e-05 | 16 | 169 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | migraine disorder, Headache | 1.39e-04 | 86 | 169 | 5 | HP_0002315, MONDO_0005277 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 1.94e-04 | 4 | 169 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.69e-04 | 99 | 169 | 5 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Cerebellar Ataxia | 3.22e-04 | 5 | 169 | 2 | C0007758 | |
| Disease | Moyamoya disease (is_implicated_in) | 3.22e-04 | 5 | 169 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | beta-1,4-galactosyltransferase 7 measurement | 4.82e-04 | 6 | 169 | 2 | EFO_0802314 | |
| Disease | Headache | 5.05e-04 | 64 | 169 | 4 | HP_0002315 | |
| Disease | coronary artery disease | DNAJC13 HINT1 DPP10 DOCK8 DYNC2H1 WBP1L RNF213 OPHN1 SNX13 TFPI NEDD9 PLEKHG1 GUCY1A1 CDC123 CSNK1G2 LRP1 DOCK6 | 5.26e-04 | 1194 | 169 | 17 | EFO_0001645 |
| Disease | Alzheimer's disease (is_marker_for) | 7.30e-04 | 257 | 169 | 7 | DOID:10652 (is_marker_for) | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 7.48e-04 | 71 | 169 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | hypospadias (is_implicated_in) | 8.93e-04 | 8 | 169 | 2 | DOID:10892 (is_implicated_in) | |
| Disease | triglyceride measurement, response to selective serotonin reuptake inhibitor | 9.69e-04 | 34 | 169 | 3 | EFO_0004530, EFO_0005658 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 9.69e-04 | 34 | 169 | 3 | EFO_0009926 | |
| Disease | uterine fibroid | 1.04e-03 | 199 | 169 | 6 | EFO_0000731 | |
| Disease | migraine disorder | 1.10e-03 | 357 | 169 | 8 | MONDO_0005277 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.10e-03 | 276 | 169 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 1.14e-03 | 9 | 169 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | Profound Mental Retardation | 1.26e-03 | 139 | 169 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.26e-03 | 139 | 169 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.26e-03 | 139 | 169 | 5 | C0917816 | |
| Disease | cytokine measurement | 1.42e-03 | 461 | 169 | 9 | EFO_0004873 | |
| Disease | executive function measurement | 1.52e-03 | 376 | 169 | 8 | EFO_0009332 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 1.67e-03 | 88 | 169 | 4 | EFO_0803332 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.73e-03 | 11 | 169 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 1.73e-03 | 11 | 169 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | creatinine measurement | DNAJC13 HINT1 A1CF PPFIA2 WBP1L BIRC6 USP20 PTPN12 DOCK7 NUMB FGF6 UNC80 DUSP11 KPNA3 | 1.83e-03 | 995 | 169 | 14 | EFO_0004518 |
| Disease | obsolete_red blood cell distribution width | KLHL24 DNAJC13 ACADS DOCK8 BIRC6 CNIH3 SNX13 CDCA2 PLEKHG1 TRIM33 CSNK1G2 RNF146 ATAD2B HFM1 DOCK6 TUBD1 PPP6R3 | 1.94e-03 | 1347 | 169 | 17 | EFO_0005192 |
| Disease | Neurodevelopmental Disorders | 2.04e-03 | 93 | 169 | 4 | C1535926 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 2.44e-03 | 13 | 169 | 2 | OBA_2045159 | |
| Disease | colon carcinoma (is_marker_for) | 2.44e-03 | 13 | 169 | 2 | DOID:1520 (is_marker_for) | |
| Disease | systemic lupus erythematosus (is_marker_for) | 2.49e-03 | 47 | 169 | 3 | DOID:9074 (is_marker_for) | |
| Disease | femoral neck bone geometry | 2.84e-03 | 14 | 169 | 2 | EFO_0004511 | |
| Disease | Prostatic Neoplasms | 3.02e-03 | 616 | 169 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.02e-03 | 616 | 169 | 10 | C0376358 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 3.26e-03 | 15 | 169 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | endometriosis | 3.40e-03 | 252 | 169 | 6 | EFO_0001065 | |
| Disease | fibrinogen measurement | 3.62e-03 | 109 | 169 | 4 | EFO_0004623 | |
| Disease | migraine without aura, susceptibility to, 4 | 3.71e-03 | 16 | 169 | 2 | MONDO_0011847 | |
| Disease | C-reactive protein measurement | SEMA4D BIN1 HINT1 OR9G1 ACADS USP20 OR9G9 ITPR1 CSNK1G2 RNF146 DOCK7 NUMB HFM1 PLD2 TUBD1 | 4.08e-03 | 1206 | 169 | 15 | EFO_0004458 |
| Disease | Amyotrophic lateral sclerosis | 4.19e-03 | 17 | 169 | 2 | cv:C0002736 | |
| Disease | Intellectual Disability | 4.38e-03 | 447 | 169 | 8 | C3714756 | |
| Disease | Endometrial Neoplasms | 4.52e-03 | 58 | 169 | 3 | C0014170 | |
| Disease | lymphocyte count | CYP2C19 ADRM1 INSRR SCD5 NIBAN3 ITPR1 TBC1D16 PTPN12 GUCY1A1 ATAD2B ERCC6L2 ZNF638 HFM1 DDX60L TUBD1 ACAP2 KPNA3 | 4.53e-03 | 1464 | 169 | 17 | EFO_0004587 |
| Disease | sphingosine 1-phosphate measurement | 4.70e-03 | 18 | 169 | 2 | EFO_0800185 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 4.70e-03 | 18 | 169 | 2 | OBA_2045155 | |
| Disease | chronotype measurement | SEMA4D ESR2 BIRC6 PREPL TRIM33 AXDND1 LRPPRC GPR61 ATAD2B QARS1 TUBD1 SMC1B | 5.00e-03 | 882 | 169 | 12 | EFO_0008328 |
| Disease | Schizophrenia | HINT1 ESR2 RB1CC1 GFRA3 CNIH3 STXBP1 TLR3 STON2 ERVK-8 LRP1 TNFRSF1B KPNA3 | 5.04e-03 | 883 | 169 | 12 | C0036341 |
| Disease | sugar consumption measurement | 5.10e-03 | 120 | 169 | 4 | EFO_0010158 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 5.23e-03 | 19 | 169 | 2 | C0751884 | |
| Disease | inosine measurement | 5.23e-03 | 19 | 169 | 2 | EFO_0010503 | |
| Disease | thrombin activatable fibrinolysis inhibitor activation peptide measurement | 5.23e-03 | 19 | 169 | 2 | EFO_0008582 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 5.23e-03 | 19 | 169 | 2 | EFO_0003100, GO_1902519 | |
| Disease | hypertension, white matter hyperintensity measurement | 5.45e-03 | 62 | 169 | 3 | EFO_0000537, EFO_0005665 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLVLDFEATCDKPQI | 146 | O43414 | |
| FLRDELCIKQEDSLF | 91 | B9A014 | |
| DILDEPFLKRACQDV | 61 | P26439 | |
| RLPKFAEEENLCIDS | 721 | Q9NR09 | |
| RATLPVFDKEELLEC | 126 | P54687 | |
| IKSCEVLFNPFDDII | 161 | Q6UX04 | |
| PECAEELAFRKGDIL | 16 | Q14511 | |
| CEIFIGKLPRDLFED | 56 | Q9NQ94 | |
| LLQTCRDFAEKELFP | 41 | P16219 | |
| GDILDEPFLKRACQD | 61 | P14060 | |
| ARKNAPCILFIDEID | 396 | Q9Y4W6 | |
| PSFQEECKFRETLLP | 151 | P10767 | |
| FIDELDALCPKREGA | 451 | Q8NB90 | |
| ELEELNLPDSCFLKA | 111 | Q9BQ75 | |
| DVNNPRDFIDCFLIK | 256 | P10632 | |
| QLLNAPDLCAKDFED | 2016 | P11532 | |
| PDLCAKDFEDLFKQE | 2021 | P11532 | |
| DFEECLKDSPRFRAA | 6 | Q15057 | |
| FKECPQLELLDLAFT | 416 | Q99467 | |
| FFSDCLKEEISVLPQ | 776 | Q8N608 | |
| CIEKIDPARFSTEDF | 546 | Q96BY7 | |
| CDFDDPRLLKNIEDR | 476 | Q9NTI2 | |
| DRFDGDVDPDLKCAL | 6 | Q9UPQ7 | |
| ERFAEAVDPALECKL | 6 | Q6ZMN7 | |
| NIIDDFFCDLLPLVE | 171 | Q8NH87 | |
| PDFRERLKCYEQELE | 16 | O60890 | |
| CAFQPEKDELLASLE | 321 | Q86XR2 | |
| TCKSELPRFQELIFE | 511 | Q96TA1 | |
| DRPNDVESLVRKCFD | 316 | Q8TDY2 | |
| DCELPDISLKDLQFL | 571 | Q8TDY2 | |
| VSPDFELRNFKVLCE | 21 | Q8WTU0 | |
| QTCPELLRKDFESLF | 151 | Q9H3L0 | |
| LQERFAVLPKCTDFD | 156 | P20585 | |
| KSLLFCFESEESPDL | 1576 | Q15058 | |
| LAEPERCNFTLAESK | 21 | P23467 | |
| KCLERDDNPSLQFEA | 121 | O00505 | |
| FVCFFKPAPEEELRL | 356 | Q9BZJ8 | |
| FAPDLVLDRDEGKCV | 356 | Q92731 | |
| FSFPDDLQCVDLKIL | 166 | P06870 | |
| NLADKAFDRPICEAL | 151 | Q96FI4 | |
| KELDVCSPEFSFLRA | 151 | Q8TAT5 | |
| LLVCAVDKRFLPDDN | 131 | Q4ZG55 | |
| DVDFRLLEKLSLENC | 441 | Q86UX2 | |
| RDVVCQRFPFSDKEK | 846 | Q14643 | |
| FFKCTVDVPEDLREA | 126 | P51114 | |
| CKAVTDEEPFLIFAN | 3021 | Q07954 | |
| AIIAAELDPEFNKLC | 1061 | Q9ULI0 | |
| QFVKALEDFEDLCDR | 161 | Q8IZU0 | |
| LEDLFDLCDRTFTLK | 126 | P78368 | |
| AFELLPDDERQCIKC | 686 | Q9BY66 | |
| ESKRDAFSPVLLQFC | 1191 | O15054 | |
| RAQELCPEEFILFKN | 1026 | Q5H9U9 | |
| DLAPKCDVSFLQSED | 881 | P52789 | |
| FTDECTFKEILLPNN | 151 | P08620 | |
| RLRCALNKSPDFEEV | 81 | Q02556 | |
| RKALEELREFCNSPD | 356 | O14524 | |
| KRVCFPSEDHLEEFI | 71 | Q9UHL3 | |
| IDLKDCFFTIPLAEQ | 121 | P63132 | |
| TEPDFQKDILIACRL | 1031 | P42704 | |
| RKIFDSEPLCLSDNL | 691 | Q8IWU2 | |
| DETFNLPRLCIRKFF | 216 | P32455 | |
| RKCFVFDRPTNDKDL | 231 | Q6ZN66 | |
| QLFDDLCEALLPAAK | 6 | Q96RT7 | |
| DILDQNRIFDPKCLD | 166 | P21266 | |
| IFCPESFDRLDLLKD | 591 | Q9NQV6 | |
| EIPAKIIFEDDRCLA | 26 | P49773 | |
| NIIDDFFCDLLPLVK | 171 | P0C7N8 | |
| IDLKDCFFTIPLAEQ | 121 | P63135 | |
| IDLKDCFFTIPLAEQ | 121 | Q9BXR3 | |
| VPEDRCFSIVFKDQR | 91 | P51178 | |
| DCLFSLENLFFEKPD | 6 | A2PYH4 | |
| IDLKDCFFTIPLAEQ | 121 | Q9QC07 | |
| EIFSQPDREEFLFCL | 156 | Q9BRQ4 | |
| LKVSAERFTDDPCFL | 101 | Q9UI47 | |
| SEEKIICLTRVFEPF | 351 | Q8NCM8 | |
| LSDCLKFQREERPLF | 546 | P10398 | |
| LRDACAKFLEEQLDP | 151 | Q6TFL4 | |
| DINNPRDFIDCFLIK | 256 | P33261 | |
| KFPELLFEEDTELCA | 1446 | Q96HP0 | |
| SKFPELLFEEETEQC | 1536 | Q96N67 | |
| ACDFDLRSLQPDKRL | 196 | Q8NF50 | |
| ECFSPLDLFNKIREQ | 116 | O75319 | |
| ELIPGAEFRCFVKEN | 171 | O75794 | |
| CLRQLLTFFEKAAEP | 196 | O60609 | |
| SLDFCSFKLENLEFP | 611 | Q5T1B0 | |
| PKLKEEEFCSFQINE | 111 | P28325 | |
| CDSENPQLFTIEFIK | 286 | O75165 | |
| LKEDPFLFCREIENG | 96 | Q6ZN28 | |
| NELASPRECIEFLKE | 1016 | P14616 | |
| SPDLNIKCERKDDFL | 756 | Q69YH5 | |
| NFFEICDELGVKRPS | 516 | P14866 | |
| EEDARPFNALCKRLS | 1391 | Q76NI1 | |
| ELEPLCLAEQDFISK | 521 | Q9NV70 | |
| AEFVKLAELPCLEDL | 131 | Q4LDG9 | |
| VKDCPRNLIFDDEDL | 86 | Q5T890 | |
| SREFQLCDPKEVARL | 266 | O00321 | |
| ELEKCRGVFPENFTE | 576 | O00499 | |
| NDDPEKCQLLFRVSD | 46 | Q8TAL6 | |
| NEDDIIFPFELHKCR | 896 | Q92622 | |
| FNPTVCDALLDKDET | 151 | Q96BU1 | |
| QDLSRFLVKRFCSEP | 1181 | O00411 | |
| PQAFDAFCEALRETK | 96 | P42575 | |
| FPETDLQEFLKECSS | 521 | Q8IZK6 | |
| NITDEELDRFKCFLP | 16 | W6CW81 | |
| ELDRFKCFLPDEFNI | 21 | W6CW81 | |
| EEEERLLKAIPLFCF | 91 | Q9H6A0 | |
| LTFLDPDCDEKLFDN | 616 | P46019 | |
| PEFAALTKELNACRE | 101 | O75334 | |
| FVLDCKDKEPDVLFV | 31 | P68402 | |
| EFLEAFRLVEKSCPE | 716 | O14830 | |
| IEKVSFCAPDRNFDR | 111 | P49757 | |
| DLFVDLVEKFVEPCR | 301 | O43427 | |
| TDCPADRLKFFETLR | 216 | Q9Y6R4 | |
| GICFLRFDDTNPEKE | 296 | P47897 | |
| SPKDEEGFLRDLCEV | 216 | Q9Y5W8 | |
| PDDFVADVRLIFKNC | 1021 | Q9UPN9 | |
| TPLLSCNLKDDFEFF | 616 | Q96DN5 | |
| ECPFLTFDDLLNRLE | 341 | O43776 | |
| NAFLKACDELTDILP | 976 | Q8NF91 | |
| ELSKSLDAFPEDFCR | 296 | Q96KG9 | |
| LESDDFVICQKPLEL | 246 | Q969F9 | |
| AFCEVRPDDKRILEF | 876 | O60502 | |
| KERLPAFLESDCYFE | 126 | Q8NE09 | |
| CDIRQFLSLRPEEKF | 1141 | O94761 | |
| CLDRVLQDFKLTPAD | 101 | A6NCM1 | |
| AFRELIAQLELDPKC | 386 | Q8N5V2 | |
| TFAPFKISCEDEQAR | 156 | Q05209 | |
| FLPDDCFILVKLSLE | 1121 | O14802 | |
| CALCRQEIPEDFLDK | 71 | Q9NTX7 | |
| IPFCDAKEEIRAGLE | 11 | Q86SK9 | |
| FEFDTRDNPKGLCDL | 136 | Q9Y484 | |
| IDDLSARDKPFDVKC | 836 | Q92854 | |
| KIFNAEVLFREDCSP | 211 | P55039 | |
| FTDSCPDALFNELVK | 106 | P61764 | |
| FDKPDFKRSIVCLED | 901 | Q8N5C6 | |
| FREFKLEICHEISEP | 471 | Q8WXE9 | |
| AFCPNALFILKVDEE | 171 | A8MXE2 | |
| KLFTFPLETCNDINE | 56 | Q9BY15 | |
| DDLIIFPDDCEFKRV | 71 | Q16186 | |
| EETKCFIFRRNEALP | 721 | Q8IYA6 | |
| IQDEPEQFCKLSIFL | 76 | A8MTZ7 | |
| FDELRTDFKSPIDQC | 31 | Q8TBE1 | |
| LASEDDFVKEFCQPV | 291 | Q9BTX7 | |
| CKNILRFIQFEPEED | 81 | Q9NUQ7 | |
| IDLKDCFFTIPLAEQ | 121 | P63136 | |
| TLDENFKSDLCDIPA | 376 | Q01973 | |
| LDIFLANLPEAKCSE | 2996 | Q63HN8 | |
| CKERFFSEEENGVPI | 46 | Q9UJT1 | |
| EALECLDDFKGKFPE | 451 | Q8N5D0 | |
| DQSLKFCLEERDFEA | 781 | O15455 | |
| LRDCFNLFTKEEELE | 416 | Q9UK80 | |
| EALLKECLEFFNIPE | 2021 | Q8N2C7 | |
| CLDESIDKIRFDPFI | 401 | Q9Y5W7 | |
| EIFDKARQAAPCVLF | 561 | P55072 | |
| ARQAAPCVLFFDELD | 566 | P55072 | |
| PCVLFFDELDSIAKA | 571 | P55072 | |
| CIRFLKEERAEPETF | 556 | Q8NDV3 | |
| LEDSFVQEFLSKDPC | 66 | Q5MJ68 | |
| LLLCFKREFPEAEAL | 611 | Q8TBP0 | |
| IDLKDCFFTIPLAEQ | 121 | P10266 | |
| IDLKDCFFTIPLAEQ | 121 | P63133 | |
| KFRECFLNLDPSKTE | 276 | Q70CQ1 | |
| VPFIKIFLDDECYRE | 571 | Q6ZS81 | |
| KEREIVEEFLFCEPL | 196 | Q8IZ13 | |
| IDLKDCFFTIPLAEQ | 121 | Q9UQG0 | |
| FNLEELKLDQPFIDC | 146 | Q4J6C6 | |
| ETLRQCFDDFADLVP | 336 | O14763 | |
| TLQQEKPDFCFLEED | 116 | P10646 | |
| CEKEVFLEQRLAAPL | 86 | Q9Y2K6 | |
| APIVSFEECERKFKA | 986 | Q9BZF9 | |
| VDPAFDKDRFLKQCE | 306 | O43615 | |
| FFKEGDVPCQIEARL | 146 | Q9UK13 | |
| LCDINEFSFELKPAR | 3516 | Q7Z7G8 | |
| DSKLRCVFELPAEND | 116 | O95292 | |
| VPFSKEECAFRSQLE | 421 | P20333 | |
| SRANCPFEEDLISKE | 911 | Q9ULL1 | |
| EFLLKAECLEDLVSF | 46 | Q5H9R7 | |
| DLDLRDPICDDFFQL | 831 | O14939 | |
| FSDPDDLLNFKLVIC | 51 | P61081 | |
| LDPGAFLDKDAECRE | 206 | Q9NX94 | |
| DGCTEEDVRKLFQPF | 686 | Q14966 | |
| IAEDLCPERDIKYFF | 81 | Q9Y2Q1 | |
| ESICKLIFPEFERLN | 76 | Q02108 | |
| AFELLPDDERQCIKC | 696 | P41229 | |
| ILRENDFEPKFLCEV | 266 | Q5T7N2 | |
| DLKDFVCDDFLKPQI | 486 | O94898 | |
| LCPDNEEFIVFVRKN | 771 | Q8N1T3 | |
| KDFDDLCSLPDLNEK | 146 | B2RTY4 |